NCT01897844View on ClinicalTrials.gov

A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DRUG

ITF2984 (100, 2000, 3000 mcg bid)

DRUG

Placebo

Trial Locations (1)

37134

Centro Ricerche Cliniche, Verona

Sponsors

Lead Sponsor

Italfarmaco
All Listed Sponsors
lead

Italfarmaco

INDUSTRY

NCT01897844 - A Two Part Phase 1, Repeated Doses and Continuous Infusion Study With ITF2984 in Healthy Volunteers | Biotech Hunter | Biotech Hunter